Yahoo Web Search

Search results

1. • KDM5B promotes SMAD4 loss-driven drug resistance through activating DLG1/YAP to induce lipid...

     Nature· 2 days ago

     Inactivated suppressor of mothers against decapentaplegic homolog (SMAD) 4 significantly affects cancer development in pancreatic ductal adenocarcinoma (PDAC). However, the ...

2. • 

     Patients Benefit From Advances at Miami Cancer Institute’s Abbhi Family Bladder Cancer Clinic

     Miami Herald via AOL· 7 days ago

     “The goal is to identify and classify the disease correctly and to determine the best treatment...

3. • 

     Ipilimumab, a Pioneer Breakthrough in Cancer Treatment

     Forbes· 6 days ago

     In 2011, the first in a new generation of anticancer drugs called checkpoint inhibitors was...

4. • 

     What Happens to Your Body When You Eat Broccoli Regularly

     Eating Well via Yahoo News· 2 days ago

     Remarkably, this potent substance has been linked to a reduced risk of various cancers, including...

5. • 

     AstraZeneca’s $80B sales plan leans on cancer drug expansion

     BioPharma Dive via Yahoo Finance· 4 days ago

     Antibody-drug conjugates, which pair the tumor-targeting of antibodies with the cell-killing power...

6. • 

     Candel (CADL) Reports Upbeat Data From Lung Cancer Study

     Zacks via Yahoo Finance· 2 days ago

     Candel's (CADL) CAN-2409 prolongs overall survival in a phase II study for treating patients with...

7. • A corner of the cancer therapy market is heating up—Here are the names investors need to know

     CNBC· 3 days ago

     There's been a lot of attention lately on a corner of the oncology market called radiopharmaceuticals. The therapy seeks to destroy cancer cells by binding a radioactive particle ...

8. • 3 hospitals piloting blood tests to detect cancer

     Becker’s Hospital Review· 5 days ago

     More hospitals and systems are testing the effectiveness of blood tests to detect cancer. Recently, the Prostate Cancer Foundation also ...

9. • 

     NCI-MATCH Precision Medicine Clinical Trial

     National Cancer Institute· 3 days ago

     NCI-MATCH, also known as MATCH, is a precision medicine cancer treatment clinical trial that sought to find out if treating cancer based on specific...

10. • ValiRx (LON:VAL) Stock Price Down 10%

      ETF DAILY NEWS· 3 days ago

      Shares of ValiRx plc (LON:VAL – Get Free Report) dropped 10% on Tuesday . The company traded as low as GBX 3.55 ($0.05) and last traded at GBX 3.60 ($0.05). Approximately 9,956,905 shares changed ...